As the critical determinant of T2DM is the loss or dysfunction of insulin-producing pancreatic β cells [47], agents capable of inducing the overexpression of PDX-1 could conceivably cure T2DM. This evidence concerns the gene PDX1 and type 2 diabetes mellitus.